image by: Madhattersdiary
To anyone who lived through the 1960s, the proposition that psychedelic drugs might have a positive contribution to make to our mental health must sound absurd. Along with hallucinogens like mescaline and psilocybin (that is, magic mushrooms), LSD was often blamed for bad trips that sent people to the psych ward. These drugs could make you crazy.
So how is it possible that, 50 years later, researchers working at institutions such as New York University, Johns Hopkins, UCLA and Imperial College in London are discovering that, when administered in a supportive therapeutic setting, psychedelics can actually make you sane? Or that they may have profound things to teach us about how the…
read full article
Studies of MDMA, ketamine, psilocybin mushrooms and other psychedelics have shown tremendous potential for therapeutic applications.
Psychedelic-therapy industry gets a reality trip as investors focus on treatments costing less time and money.
Psychedelic drugs are still classified as Schedule 1 drugs, or drugs with no current accepted medical use and a high potential for abuse. But as regulations around these drugs are beginning to loosen, they’re becoming accepted treatments for a host of mental health issues—and fueling what many call a psychedelic renaissance.
For antiprohibitionists who are wondering what comes next after marijuana legalization, this class of drugs seems like a good place to start.
Scientists are taking a new look at hallucinogens, which became taboo among regulators after enthusiasts like Timothy Leary promoted them in the 1960s with the slogan “Turn on, tune in, drop out.”
With psychedelic drugs becoming more socially acceptable, taking them in the club also feels less dangerous. “People used to be very careful because they were scared of tripping,” says Nabben. “But now they’re experimenting with smaller doses, which allows them to use them in different settings. These doses can be combined with other substances, too.”
As it turns out, nutmeg contains a psychoactive element called myristicin, whose chemical structure shares similarities with mescaline, amphetamine, and ecstasy. A Dictionary of Hallucinations—let us pause for a moment to give thanks that we live in a world where such a reference exists—notes that nutmeg has been “reported to mediate visual, auditory, tactile, and kinaesthetic hallucinations (notably the sensation of floating).” This is not breaking news: the Benedictine abbess Hildegard of Bingen noted the mind-altering effects of nutmeg all the way back in the 12th century.
It came as a surprise to many when, on Feb. 3, Australian regulators announced that medicines containing the psychedelic substances MDMA and psilocybin can soon be used there to treat post-traumatic stress disorder (PTSD) and treatment-resistant depression, respectively. That decision makes Australia the first country in the world to formally recognize the therapeutic use of psychedelics.
Other countries, including the U.S., may be headed toward a similar outcome, some experts say.
Reshaping your mind isn’t always a great idea.
The numbers indicate a growing movement of people unwilling to wait for LSD and psilocybin to be legalised.
One reason psychedelics may work: They treat the person’s context, not just their illness.
As hallucinogens get a renewed look by researchers, they're finding that the substances may improve almost anyone's mood and quality of life — as long as they're taken in the right setting, typically a controlled environment.
With popular drugs like ketamine and psilocybin making their way into recent stories and novels, altering characters, expediting climaxes and dictating narratives, is fiction changing forever?
Even with cause for concern, retreats in countries like Costa Rica and Jamaica, as well as in the United States, have been popping up for more than a decade.
The annual U.S. survey of substance use captures the growing mainstream acceptance of cannabis and hallucinogenic compounds.
Recent studies are finding that drugs such as LSD and psilocybin can help to alleviate depression, anxiety and addiction—and may have profound things to teach us about how the mind works.
Our mission at Psychedelic Times is to share the latest news, research, and happenings around the study of psychedelics as tools of healing, recovery, and therapy. We are passionate about the incredible potential that psychoactive substances such as marijuana, ayahuasca, MDMA, LSD, iboga, psilocybin, and DMT present to humanity, and are excited to share that passion with you.
Learn more about hallucinogens and the problems they can cause...Hallucinogens.com helps you help yourself and others.
Multiple articles including Humphrey Osmond's The Exploration of Experience 1957.